CF PHARMTECH: Pyramid Investment Limited Acquires Shares, Long Position Rises to 14.3%
HK Disclosure
Oct 02
Pyramid Investment Limited bought 25,100 H-shares of CF PHARMTECH (02652) on the SEHK open market on September 28, 2026, at an average price of HKD 7.2916 per share, with a total consideration of approximately HKD 183,019. This is an on-exchange active trade, i.e. a direct dealing in the secondary market.
Prior to the acquisition, Pyramid Investment Limited's long position in CF PHARMTECH was 46.29 million shares, representing 14.29%; following the acquisition, the holding increased to 46.32 million shares, with the long position ratio rising to 14.3%.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.